Cross-border · Research collaboration · Belgium
Interreg FIT project to host Meuse-Rhine regenerative medicine conference in Genk on 4 December
FIT, an EU Interreg-funded project led by Bert Smeets of Maastricht University, will stage a conference on muscle-disease therapies in Genk, Belgium, on 4 December 2026.
Why it matters: Researchers, firms, clinicians and patient groups working on regenerative medicine in the Meuse-Rhine region are the conference's intended audience on 4 December.
Maastricht University said the FIT group, which receives EU Interreg funding, will stage the Regenerative Medicine Meuse-Rhine (RMMR) Conference at the Thor Central venue in Genk, Belgium, on 4 December 2026, concentrating on emerging treatments for muscle disease and loss of muscle mass.
The university said Giulio Cossu, who holds a chair in regenerative medicine at the University of Manchester, is due to deliver the opening keynote, while the afternoon programme features an Impact Marketplace of posters, company stands and live demonstrations.
According to the university, Bert Smeets of Maastricht University leads FIT, short for Fitness Improving Technology, a project partnering universities based in Maastricht, Leuven, Liège, Hasselt and Aachen with four companies: Revatis, ReWrite, Scinus and Milocron.
Editor’s view
Joseph Lopez, Collaboration Editor
Researchers, companies, clinicians and patient groups in the Meuse-Rhine region who want to engage with the FIT consortium's work on muscle therapies can meet it in Genk on 4 December 2026.
What to watch
- The RMMR Conference is scheduled for 4 December 2026 at Thor Central in Genk.
